{"id":563737,"title":"Community Pharmacy Inspection Program discovers drug diversion in Hamilton pharmacy - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T17:49:04.797000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/compliance-enforcement/community-pharmacy-inspection-program-spotlight-5-2019.html","snippet":"Community Pharmacy Inspection Program discovers drug diversion in Hamilton pharmacy Health Canada helps protect Canadians by minimizing the diversion and problematic use of controlled substances such as such as oxycodone, morphine, fentanyl and benzodiazepines. Health Canada’s…","rawSnapshotUrl":"/api/snapshots/raw/563737","browseUrl":"https://replay.healtharchive.ca/job-6/20260216174904/https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/compliance-enforcement/community-pharmacy-inspection-program-spotlight-5-2019.html#ha_snapshot=563737","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}